Animal studies showed that VEGF receptor blockers or a single dose of anti-VEGF impaired pulmonary vascular growth and postnatal alveolarization and caused pulmonary hypertension in infant rats13,43,44. Here, VEGFA is linked to pulmonary arterial hypertension.